David Bouchey
Stock Analyst at Aegis Capital
(n/a)
# 4,869
Out of 5,090 analysts
8
Total ratings
n/a
Success rate
-49.71%
Average return
Main Sectors:
Stocks Rated by David Bouchey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SBFM Sunshine Biopharma | Reiterates: Buy | $7 | $1.43 | +389.51% | 3 | Oct 8, 2025 | |
| AEON AEON Biopharma | Reiterates: Buy | $7.2 | $0.67 | +971.59% | 1 | Oct 8, 2025 | |
| STSS Sharps Technology | Initiates: Buy | $105,600 | $2.46 | +4,292,582.93% | 1 | May 9, 2023 | |
| IINN Inspira Technologies Oxy B.H.N. | Maintains: Buy | $10 → $13 | $1.11 | +1,071.17% | 1 | Jan 25, 2023 | |
| RMTI Rockwell Medical | Downgrades: Outperform | $121 | $0.99 | +12,160.61% | 2 | Oct 19, 2018 |
Sunshine Biopharma
Oct 8, 2025
Reiterates: Buy
Price Target: $7
Current: $1.43
Upside: +389.51%
AEON Biopharma
Oct 8, 2025
Reiterates: Buy
Price Target: $7.2
Current: $0.67
Upside: +971.59%
Sharps Technology
May 9, 2023
Initiates: Buy
Price Target: $105,600
Current: $2.46
Upside: +4,292,582.93%
Inspira Technologies Oxy B.H.N.
Jan 25, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $1.11
Upside: +1,071.17%
Rockwell Medical
Oct 19, 2018
Downgrades: Outperform
Price Target: $121
Current: $0.99
Upside: +12,160.61%